The Effects of Nonsurgical Periodontal Therapy on Serum Levels of Procalcitonin in Patients with Chronic and Aggressive Periodontitis

Önder, Canan; Kurgan, Şivge; Balcı, Nur; Tayman, Ayşe; Güney, Zeliha; Serdar, Muhittin; Günhan, Meral

doi:10.21506/j.ponte.2016.4.8

Ponte 2016

DOI: 10.21506/j.ponte.2016.4.8

|View full text |Cite

The Effects of Nonsurgical Periodontal Therapy on Serum Levels of Procalcitonin in Patients with Chronic and Aggressive Periodontitis

Canan Önder¹,

Şivge Kurgan²,

Nur Balcı³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The levels of cartonectin and procalcitonin in patients with chronic periodontitis and hypertension

Ata¹,

Çanakçı

Karasu

2023

Turkish Journal of Biochemistry

View full text Add to dashboard Cite

Objectives This study aimed to examine the effects of chronic periodontitis and essential hypertension on serum and salivary cartonectin (CTRP3) and procalcitonin (ProCT) levels. Methods 60 non-smokers were seperated into four groups as; 15 people with essential hypertension (EH) and chronic periodontitis (CP) (HT+ CP+), 15 with EH (HT+ CP-), 15 with CP (HT- CP+), 15 control (HT- CP-). PPD, CAL, PI and GI were measured. All groups had their serum and saliva samples collected. Serum and saliva procalcitonin (ProCT) were measured using an electroluminescence method, and cartonectin (CTRP3) levels were determined by enzyme-linked immunosorbent assay. Results When compared to the control group, serum and saliva cartonectin (CTRP3) levels were considerably lower in all groups (respectively p<0.0001, p<0.0001). The serum cartonectin (CTRP3) levels were substantially higher in the HT- CP+ group than in the HT+ CP- group (p=0.002). Serum procalcitonin (ProCT) concentrations were found to be lowest in the HT- CP- group and highest in the HT+ CP+ group. Serum ProCT concentrations did not vary significantly across groups (p=0.110). Salivary procalcitonin (ProCT) levels were below the detection limit in all groups. Conclusions When periodontitis coexist with hypertension in individuals, they may have adversely affect each other due to the same sathways in the pathogenesis of these two disorders. So we can suggest that, serum and saliva cartonectin (CTRP3) may play a role during hypertension and periodontal inflammation and represent a novel future therapeutic target.

show abstract

The levels of cartonectin and procalcitonin in patients with chronic periodontitis and hypertension

Ata¹,

Çanakçı

Karasu

2023

Turkish Journal of Biochemistry

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The Effects of Nonsurgical Periodontal Therapy on Serum Levels of Procalcitonin in Patients with Chronic and Aggressive Periodontitis

Cited by 1 publication

References 0 publications

The levels of cartonectin and procalcitonin in patients with chronic periodontitis and hypertension

The levels of cartonectin and procalcitonin in patients with chronic periodontitis and hypertension

Contact Info

Product

Resources

About